The Androgen Deprivation Therapy Educational Program

The ADT Educational Program team is the recipient of the 2019 Canadian Association of Psychosocial Oncology (CAPO) Innovation Award, conferred for “the development of quality improvement and innovative clinical, educational, or organizational initiatives aimed at enhancing the performance of psychosocial cancer care or cancer prevention”.

What is the ADT Program?

Androgen Deprivation Therapy (ADT) is an effective treatment for prostate cancer, but has many side effects. The ADT Educational Program is a free 1.5-hour session during which patients and loved ones will:

Learn about side effects of ADT
Learn how to manage side effects
Complete goal setting exercises to teach you how to manage ADT side effects

The program is designed for both patients and their partners or loved ones.

Canadian participants receive a free copy of the book Androgen Deprivation Therapy: An Essential Guide for Prostate Cancer Patients and Their Loved Ones.

The ADT Educational Program is supported by grants and donations. If you have found the services provided by the program helpful to you or your family members and want to help keep the program going, feel free to donate to the Prostate Cancer Centre in Calgary. Mark your donation as "For the ADT Educational Program". Donations over $20 will receive a Canadian tax receipt.

Watch to learn more about the program:

Who can join?

This program is suitable for all patients on ADT. We encourage patients to join the program “preemptively”—i.e., before they start ADT or as soon as possible after starting on ADT. That being said, patients who have been on ADT for any length of time are still welcome to attend. Participation is free of charge.

We thank Astellas Pharma Canada for an unrestricted educational grant to initiate the online ADT Educational Program in Canada. The online ADT Educational Program is hosted by the Prostate Cancer Centre in Calgary. The development of an earlier version of the online ADT Educational Program was supported by TrueNTH Canada, awarded by Prostate Cancer Canada and proudly funded by the Movember Foundation.